In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell–Related Injury
Drug repurposing is a valuable strategy for rare diseases. Sickle cell disease (SCD) is a rare hereditary hemolytic anemia accompanied by acute and chronic painful episodes, most often in the context of vaso-occlusive crisis (VOC). Although progress in the knowledge of pathophysiology of SCD have al...
Main Authors: | Enrica Federti, Alessandro Matte, Antonio Recchiuti, Francesca Garello, Alessandra Ghigo, Wassim El Nemer, Enzo Terreno, Angela Amoresano, Domenico Mattoscio, Franco Turrini, Christophe Lebouef, Anne Janin, Antonella Pantaleo, Roberta Russo, Mickael Marin, Iana Iatcencko, Veronica Riccardi, Angela Siciliano, Achille Iolascon, Carlo Brugnara, Lucia De Franceschi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-03-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000848 |
Similar Items
-
Precision Medicine and Sickle Cell Disease
by: Sara El Hoss, et al.
Published: (2022-09-01) -
P1483: EPELEUTON, A NOVEL SYNTHETIC SECOND GENERATION W-3 FATTY ACID, PROTECTS HUMANIZED SICKLE CELL MICE AGAINST HYPOXIA/REOXYGENATION ORGAN DAMAGE
by: E. Federti, et al.
Published: (2022-06-01) -
Dietary ω-3 Fatty Acid Supplementation Improves Murine Sickle Cell Bone Disease and Reprograms Adipogenesis
by: Maria Teresa Valenti, et al.
Published: (2021-05-01) -
Gender differences in the complications of sickle cell anemia
by: Angela O Ugwu
Published: (2022-01-01) -
Bioimpedance single cell sensing of low and high density sickle erythrocytes using microfluidics
by: Tieying Xu, et al.
Published: (2022-05-01)